BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 164 filers reported holding BLUEBIRD BIO INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,618,845 | -2.2% | 5,137,778 | +5.8% | 0.56% | +13.0% |
Q2 2023 | $15,977,299 | +247.6% | 4,856,322 | +236.0% | 0.49% | +251.4% |
Q1 2023 | $4,595,917 | -6.4% | 1,445,257 | +103.7% | 0.14% | -6.7% |
Q4 2022 | $4,909,941 | +31.7% | 709,529 | +20.4% | 0.15% | +23.0% |
Q3 2022 | $3,729,000 | +43.4% | 589,083 | +880.4% | 0.12% | +110.3% |
Q4 2020 | $2,600,000 | -49.2% | 60,085 | -36.6% | 0.06% | -66.7% |
Q3 2020 | $5,116,000 | -20.9% | 94,821 | -10.5% | 0.17% | -25.6% |
Q2 2020 | $6,468,000 | – | 105,966 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |